TCT 230: Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk: A Post-Hoc Analysis of the TWILIGHT Trial

Presenter: Mauro Gitto

REGISTER for free or LOG IN to view this content

TCT 230: Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk: A Post-Hoc Analysis of the TWILIGHT Trial

We Recommend